Intentar ORO - Gratis
Good deeds, numbers: Auditor drought
Mint Mumbai
|September 26, 2025
A recent move by the Securities and Exchange Board of India has spotlighted the small but crucial industry of social impact asses-sors
A recent move by the Securities and Exchange Board of India (Sebi) to refine compliance rules for the Social Stock Exchange (SSE) has spotlighted the small but crucial industry of social impact assessors.
This specialized group, responsible for verifying the real-world impact of social enterprises, is now facing a surge in demand that is severely testing its capacity.
As nonprofits increasingly turn to the SSE to raise funds, the credibility of this new-age platform rests on the shoulders of its auditors. They must ensure that every rupee raised translates into genuine, measurable social change.
However, with a limited pool of qualified professionals, the sector is grappling with a potential supply-demand gap, a lack of standardized practices and the immense challenge of quantifying social good.
This has shifted the focus from the SSE itself to the ecosystem of auditors tasked with upholding its integrity.
Launched in 2022, the SSE framework initially mandated that all registered social enterprises (SEs) submit an audited Annual Impact Report (AIR). But a Sebi circular on 19 September 2025 recalibrated this rule, restricting the mandatory audit to only those SEs that have successfully raised funds through the exchange.
Esta historia es de la edición September 26, 2025 de Mint Mumbai.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Mint Mumbai
Mint Mumbai
Gen Alpha will make new rules for their workplace
Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’
3 mins
December 01, 2025
Mint Mumbai
EC extends electoral roll revision by a week to II Dec; final list on 14 Feb
The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.
2 mins
December 01, 2025
Mint Mumbai
THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS
These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.
3 mins
December 01, 2025
Mint Mumbai
Green hydrogen: Fast fashion could help bump up demand
A boom in its use for clean synthetic inputs might make a difference
3 mins
December 01, 2025
Mint Mumbai
Let's be a bit more selective in using the word 'reforms'
Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.
3 mins
December 01, 2025
Mint Mumbai
As mid-cap alpha shrinks, should you consider passive strategies?
Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey
4 mins
December 01, 2025
Mint Mumbai
With $2.2 bn fund, ChrysCap has appetite for riskier bets
MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing
3 mins
December 01, 2025
Mint Mumbai
GDP growth of 8% plus: How to sustain this pace
Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships
2 mins
December 01, 2025
Mint Mumbai
INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES
Detection tools today are not universal or consistent across languages
5 mins
December 01, 2025
Mint Mumbai
APIs to innovation: Bulk drug makers ramp up CDMO bets
Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.
2 mins
December 01, 2025
Listen
Translate
Change font size

